Exact Mass: 661.2570063999999
Exact Mass Matches: 661.2570063999999
Found 74 metabolites which its exact mass value is equals to given mass value 661.2570063999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Streptomycin 3-phosphate
A streptomycin phosphate having the phosphate group placed at the 3-position.
ZINOSTATIN
Asp Arg Trp Trp
Asp Trp Arg Trp
Asp Trp Trp Arg
Phe Phe Trp Tyr
C38H39N5O6 (661.2900193999999)
Phe Phe Tyr Trp
C38H39N5O6 (661.2900193999999)
Phe Trp Phe Tyr
C38H39N5O6 (661.2900193999999)
Phe Trp Tyr Phe
C38H39N5O6 (661.2900193999999)
Phe Tyr Phe Trp
C38H39N5O6 (661.2900193999999)
Phe Tyr Trp Phe
C38H39N5O6 (661.2900193999999)
Met Trp Tyr Tyr
C34H39N5O7S (661.2570063999999)
Met Tyr Trp Tyr
C34H39N5O7S (661.2570063999999)
Met Tyr Tyr Trp
C34H39N5O7S (661.2570063999999)
Arg Asp Trp Trp
Arg Trp Asp Trp
Arg Trp Trp Asp
Trp Asp Arg Trp
Trp Asp Trp Arg
Trp Phe Phe Tyr
C38H39N5O6 (661.2900193999999)
Trp Phe Tyr Phe
C38H39N5O6 (661.2900193999999)
Trp Met Tyr Tyr
C34H39N5O7S (661.2570063999999)
Trp Arg Asp Trp
Trp Arg Trp Asp
Trp Trp Asp Arg
Trp Trp Arg Asp
Trp Tyr Phe Phe
C38H39N5O6 (661.2900193999999)
Trp Tyr Met Tyr
C34H39N5O7S (661.2570063999999)
Trp Tyr Tyr Met
C34H39N5O7S (661.2570063999999)
Tyr Phe Phe Trp
C38H39N5O6 (661.2900193999999)
Tyr Phe Trp Phe
C38H39N5O6 (661.2900193999999)
Tyr Met Trp Tyr
C34H39N5O7S (661.2570063999999)
Tyr Met Tyr Trp
C34H39N5O7S (661.2570063999999)
Tyr Trp Phe Phe
C38H39N5O6 (661.2900193999999)
Tyr Trp Met Tyr
C34H39N5O7S (661.2570063999999)
Tyr Trp Tyr Met
C34H39N5O7S (661.2570063999999)
Tyr Tyr Met Trp
C34H39N5O7S (661.2570063999999)
Tyr Tyr Trp Met
C34H39N5O7S (661.2570063999999)
Suc-Ala-Ala-Pro-Phe-AMC
Suc-AAPF-AMC is an α-chymotrypsin fluorogenic substrate for the quantitative determination of chymotrypsin activity[1].
5-[2,3-Dichloro-4-(5-{1-[2-(2-guanidino-4-methyl-pentanoylamino)-acetyl]-piperidin-4-YL}-1-methyl-1H-pyrazol-3-YL)-phenoxymethyl]-furan-2-carboxylic acid
C30H37Cl2N7O6 (661.2182241999999)
[11-[4,5-Dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy-4-(2-oxo-1,3-dioxolan-4-yl)-5-oxatricyclo[8.3.0.04,6]tridec-1(13)-en-2,7-diyn-12-yl] 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D009676 - Noxae > D003603 - Cytotoxins D000970 - Antineoplastic Agents
2-{4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-methoxycarbonyl-phenyl}-2-fluoro-malonic acid
7-[(2R,3R,4S,5R)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyl)oxyoxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-2-oxochromen-4-olate
(2S)-2-amino-5-[[(1S)-1-carboxy-4-[[(1S)-1-carboxy-4-[2-[4-[[5-(formamidomethyl)furan-3-yl]methoxy]phenyl]ethylamino]-4-oxobutyl]amino]-4-oxobutyl]amino]-5-oxopentanoic acid
C30H39N5O12 (661.2595094000001)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
C31H39N3O9S2 (661.2127604000001)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
C31H39N3O9S2 (661.2127604000001)
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
C31H39N3O9S2 (661.2127604000001)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
C31H39N3O9S2 (661.2127604000001)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
C31H39N3O9S2 (661.2127604000001)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
C31H39N3O9S2 (661.2127604000001)
(5s)-5-[(2s,3s,4s,5s,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-{[(2r)-2-methylbutanoyl]oxy}ethyl]oxan-2-yl]oxy}oxan-2-yl]-2-amino-5-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid
5-{6-[(acetyloxy)methyl]-3,5-dihydroxy-4-[(5-hydroxy-4-methoxy-6-methyl-5-{1-[(2-methylbutanoyl)oxy]ethyl}oxan-2-yl)oxy]oxan-2-yl}-2-amino-4-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid
(4s,6r,11r,12r)-11-{[(2r,3r,4r,5r,6r)-4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy}-4-[(4r)-2-oxo-1,3-dioxolan-4-yl]-5-oxatricyclo[8.3.0.0⁴,⁶]tridec-1(13)-en-2,7-diyn-12-yl 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate
(3s,4s)-3-[(2r,3r,4r,5s,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyl-5-[(1r)-1-{[(2s)-2-methylbutanoyl]oxy}ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,4-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
(8s)-10-{[(4s,5s,6s)-4-amino-5-[(1r,3s)-3-hydroxy-1-{[(2s)-1-hydroxypropan-2-yl]oxy}butoxy]-6-methyloxan-2-yl]oxy}-1,6,8,11-tetrahydroxy-8-[(1r)-1-hydroxyethyl]-9,10-dihydro-7h-tetracene-5,12-dione
4,7-bis(acetyloxy)-3-(benzoyloxy)-13a-hydroxy-2,9,9,12-tetramethyl-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate
C37H43NO10 (661.2886818000001)
(3s)-3-[(2s,3s,4s,5s,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-{[(2r)-2-methylbutanoyl]oxy}ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
3-{6-[(acetyloxy)methyl]-3,5-dihydroxy-4-[(5-hydroxy-4-methoxy-6-methyl-5-{1-[(2-methylbutanoyl)oxy]ethyl}oxan-2-yl)oxy]oxan-2-yl}-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
(2s,3s,3ar,4r,7r,8s,12s,13ar)-4,7-bis(acetyloxy)-3-(benzoyloxy)-13a-hydroxy-2,9,9,12-tetramethyl-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate
C37H43NO10 (661.2886818000001)